| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/16/2008 | EP1878805A2 Synthetic antigen for the detection of antibodies immunoreactive with HIV virus |
| 01/16/2008 | EP1878743A2 Urotensin-II agonists and antagonists |
| 01/16/2008 | EP1878741A2 Antagonistic peptides of prostaglandin E2 receptor subtype EP4 |
| 01/16/2008 | EP1878720A1 Process for preparing chiral bicycloprolinates as intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/16/2008 | EP1878438A2 Ligand/llytic peptide compositions and methods of use |
| 01/16/2008 | EP1877424A1 Inhibitors of protein kinases and uses thereof |
| 01/16/2008 | EP1877423A2 Htm4 used for cell-cycle regulation through its interaction with kap |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1091753B1 Antiproliferative and antiviral proteins and peptides |
| 01/16/2008 | EP1077998B1 Labelled glutamine and lysine analogues |
| 01/16/2008 | EP1032587B1 Novel exendin agonist compounds |
| 01/16/2008 | EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/16/2008 | CN101107267A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 01/16/2008 | CN101107266A Peptides with neuropeptide-2 receptor (Y2R) agonist activity |
| 01/16/2008 | CN101107265A Cyclic nonapeptide amides |
| 01/16/2008 | CN101107264A C5a receptor antagonists |
| 01/15/2008 | US7319088 Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| 01/10/2008 | WO2008003943A2 Inhibition of alpha-synuclein aggregation |
| 01/10/2008 | WO2008003707A2 Minimized small peptides with high affinity for factor viii and factor viii-like proteins |
| 01/10/2008 | WO2007109620A3 Macrocyclic peptides and methods for making and using them |
| 01/10/2008 | WO2007053512A3 Novel protein transduction domains and uses therefor |
| 01/10/2008 | WO2007027947A3 Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport |
| 01/10/2008 | US20080009604 Novel polypeptide and process for producing the same |
| 01/10/2008 | US20080009435 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |
| 01/10/2008 | US20080009068 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 01/10/2008 | US20080008712 Novel Phosphorylated Sequences of the Phosphatase Cdc25B, Antibodies for Said Sequences and Use Thereof |
| 01/10/2008 | US20080008707 Denatured collagen peptides and uses thereof |
| 01/10/2008 | US20080008683 Polypeptide Sequence Involved in the Modulation of the Immunosuppresive Effect of Viral Proteins |
| 01/10/2008 | US20080008655 Cyanine dye bioconjugates useful for diagnostic imaging and therapy; for photoacoustic imaging and detection of tumors; do not aggregate in solution, form starburst dendrimers, are capable of absorbing or omitting light in the near infrared region; Bis(ethylcarboxymethyl)indocyanine Dye |
| 01/10/2008 | DE69133552C5 Deoxyribonucleic acid sequence encoding non-A, non-B hepatitis virus - obtd. Hutch C59 subgroup encoding polypeptide(s), useful as vaccines, and immuno reactive ABS for diagnosis of virus |
| 01/10/2008 | DE19933492B4 Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen, Verfahren zu dessen Herstellung und dessen Verwendung A conjugate for placement of a cell, or membrane compartment-specific transport of active substances, a process for its preparation and its use |
| 01/10/2008 | CA2656287A1 Inhibition of alpha-synuclein aggregation |
| 01/09/2008 | EP1876184A1 A method for isolating and purifying immuno-modulating polypeptide from cow placenta |
| 01/09/2008 | EP1876183A1 Minimized small peptides with high affinity for factor VIII and factor VIII-like proteins |
| 01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/09/2008 | EP1874800A1 Diagnostic and therapeutic agents |
| 01/09/2008 | EP1527086B1 Compounds binding to p-selectin |
| 01/09/2008 | EP1371664B1 Wti modified peptide |
| 01/09/2008 | EP1115416B1 Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2008 | CN101103108A HLA-binding peptides, DNA fragments encoding the same and recombinant vectors |
| 01/09/2008 | CN100360937C Assay of isomerised and/or optically inverted proteins and protein fragments |
| 01/09/2008 | CN100360564C Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 01/09/2008 | CN100360554C Peptide conjugate |
| 01/09/2008 | CN100360553C Compounds and use thereof to modify transport across cell membranes |
| 01/08/2008 | US7317084 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 01/08/2008 | US7317077 Neural thread proteins (NTP); antiproliferative agents |
| 01/08/2008 | US7317000 Glucose-dependent insulins |
| 01/08/2008 | US7316996 For stimulating macrophages, for stimulating antibody synthesis, for combating infection, as an immunostimulant, in particular in relation to tumors, for preventing and treating septicaemic shock, for wound healing and as an adjuvant for vaccines |
| 01/08/2008 | CA2225183C Novel foam proteins and use thereof |
| 01/08/2008 | CA2203631C Cyclic peptide obtained from actinomyces s. nobilis useful as therapeutic agent |
| 01/08/2008 | CA2145826C Lipopeptide derivatives, a process for their preparation and their use |
| 01/08/2008 | CA2104111C Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 01/04/2008 | CA2595164A1 An antibody which recognizes phosphorylated polypeptides |
| 01/03/2008 | WO2008000870A1 Organic compounds that inhibit the catalytic activity of the cyclin-dependent cyclin a/kinase 2 complex by means of bonding thereof to a new pharmacophoric site in the cyclin molecule |
| 01/03/2008 | WO2008000079A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/03/2008 | WO2007129077A3 Imaging agent |
| 01/03/2008 | US20080004428 A neuregulin, epidermal growth factor, ligands for the ErbB/HER receptors; detecting EGFH2 polypeptides or mRNA for diagnostic and prognostic purposes; anticarcinogenic agents; antitumor agents; pancreatic cancer/tumor |
| 01/03/2008 | US20080004211 Inhibitors of Amyloid Fibril Formation and Uses Thereof |
| 01/03/2008 | US20080003618 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a b-cell associated protein |
| 01/03/2008 | US20080003200 Tissue selective binding for prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer |
| 01/03/2008 | CA2653756A1 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
| 01/02/2008 | EP1872134A2 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 01/02/2008 | EP1871787A2 Polymyxin b analogs for lps detoxification |
| 01/02/2008 | EP1871786A1 Peptide vaccine for influenza virus |
| 01/02/2008 | EP1871785A2 Compositions and methods for fusion protein separation |
| 01/02/2008 | EP1548027B1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 01/02/2008 | EP1539214A4 Thrombin peptide derivatives |
| 01/02/2008 | EP1502116B1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
| 01/02/2008 | EP1317476B1 Reagents for cell selection and methods of use |
| 01/02/2008 | CN101098884A Methods for the specific production of lysobactin fragments |
| 01/02/2008 | CN101096671A Blood vessel formation inhibitor HM-X and its preparation method and application |
| 01/02/2008 | CN101096382A Aglyco products and methods of use |
| 01/02/2008 | CN101096381A Blood group A antigen epitope mimic peptide and its filtration method |
| 01/02/2008 | CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 01/02/2008 | CN100358901C Cross-linked glycopeptide-cephalosporin antibiotics |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 01/01/2008 | US7314866 designing a peptide or chemical to mimic the Bax-suppressing function of VPMLKE, VPMLK, PMLKE or PMLK; apoptosis resistance |
| 01/01/2008 | US7314865 inducing lypolysis using a nucleic acid expression vector coding for an insect adipokinetic hormone polypeptide; cyclization and amidation; dietetics; drug screening |
| 01/01/2008 | US7314863 Administering cyclic peptides; arthritis, inflammations, osteoporosis, retinopathies, contraception |
| 01/01/2008 | US7314861 For increasing appetite in a subject, for research |
| 01/01/2008 | US7314858 Isolated polypeptide; nonhemolytic, minimal in vitro cytotoxicity |
| 01/01/2008 | US7314729 Using bioassay to confirm inhibition of kinase activity; comprising reporter compound, amino acids and peptidase that cleaves non-phosphorylated peptide substrates, monitor reporter output, output differs when bound to phosphorylated amino acids |
| 01/01/2008 | US7314726 Comprises modulatory peptides which bind to beta-site amyloid precursor protein cleaving enzyme (BACE) active site; for treatment of neurodegenerative diseases; prodrugs |
| 01/01/2008 | US7314626 Peptide antibiotic conjugate for use in recognition and elimination of infections agents or neoplasms; antitumor agents; bactericides |
| 12/27/2007 | WO2007148847A1 Stabilized vitamin c derivatives having a peptide molecule, preparation method thereof, and composition containing the same |
| 12/27/2007 | WO2007148837A1 Composition capable of promoting the production of collagen |
| 12/27/2007 | WO2007148804A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148803A1 Composition capable of promoting the production of hyaluronic acid |
| 12/27/2007 | WO2007148334A1 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 12/27/2007 | WO2007148089A2 Radiolabelling methods |
| 12/27/2007 | WO2007126941A3 Solid support reagents for synthesis |
| 12/27/2007 | WO2007109118A9 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS |
| 12/27/2007 | US20070299013 Exosite-Directed Thrombin Inhibitors |
| 12/27/2007 | US20070299007 Muteins OF Fibroblast Growth Factor 21 |
| 12/27/2007 | US20070298494 Channel forming peptides |
| 12/27/2007 | US20070298437 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a chloride intracellular channel 1 protein |
| 12/26/2007 | EP1870419A2 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 12/26/2007 | EP1869210A2 Peptide stabilizer compounds and screening method |